tirzepatide summit trial cardiovascular outcome Effects of on circulatory overload and end-organ damage in heart failure with Real-world efficacy of tirzepatide in

The Diabetes Prevention Program (DPP) found that people who made lifestyle changes lost more weight than those who took metformin alone

Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF

See our prior blog GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List, dated October 23, 2024

Employers should be aware of this potential risk when designing coverage and utilization management policies

and they should offer durable protection, potentially lifelong, after one or a limited number of doses (Table 1)

Your bariatric surgery teamincluding your surgeon, dietitian, and potentially an endocrinologist or obesity medicine specialistmust be involved in this decision-making process